beta blocker: be contraindicated in pulmonary edema

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be contraindicated in pulmonary edema 1.00
be contraindicated in edema 0.97
cause pulmonary edema 0.94
be contraindicated in vascular disease 0.91
be contraindicated in myasthenia gravis 0.91
be contraindicated in pheochromocytoma 0.90
be contraindicated in peripheral vascular disease 0.90
be contraindicated in stenosis 0.90
be contraindicated in asthma 0.89
be contraindicated in patients with asthma 0.89

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.42
Rule weight: 0.66
Evidence weight: 0.70
Similarity weight: 0.90
Evidence: 0.48
Plausible(vasodilator, be contraindicated in stenosis) ⋁
Evidence: 0.58
¬ Typical(beta blocker, be contraindicated in pulmonary edema)
0.40
Rule weight: 0.66
Evidence weight: 0.64
Similarity weight: 0.94
Evidence: 0.37
Plausible(agent, cause pulmonary edema) ⋁
Evidence: 0.58
¬ Typical(beta blocker, be contraindicated in pulmonary edema)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.85
Similarity weight: 0.94
Evidence: 0.60
Plausible(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.37
¬ Plausible(agent, cause pulmonary edema)
0.07
Rule weight: 0.09
Evidence weight: 0.81
Similarity weight: 0.90
Evidence: 0.60
Plausible(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.48
¬ Plausible(vasodilator, be contraindicated in stenosis)

Remarkability exclusitivity betweem a parent and a child

0.45
Rule weight: 0.58
Evidence weight: 0.83
Similarity weight: 0.94
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.22
¬ Remarkable(agent, cause pulmonary edema)
0.20
Rule weight: 0.58
Evidence weight: 0.39
Similarity weight: 0.90
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.82
¬ Remarkable(vasodilator, be contraindicated in stenosis)

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.51
Similarity weight: 0.89
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.65
¬ Remarkable(atenolol, be contraindicated in asthma)

Remarkability from parent implausibility

0.36
Rule weight: 0.42
Evidence weight: 0.91
Similarity weight: 0.94
Evidence: 0.37
Plausible(agent, cause pulmonary edema) ⋁
Evidence: 0.75
Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.60
¬ Plausible(beta blocker, be contraindicated in pulmonary edema)
0.35
Rule weight: 0.42
Evidence weight: 0.92
Similarity weight: 0.90
Evidence: 0.48
Plausible(vasodilator, be contraindicated in stenosis) ⋁
Evidence: 0.75
Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.60
¬ Plausible(beta blocker, be contraindicated in pulmonary edema)

Remarkability from sibling implausibility

0.48
Rule weight: 0.60
Evidence weight: 0.89
Similarity weight: 0.89
Evidence: 0.60
Plausible(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.65
Remarkable(atenolol, be contraindicated in asthma) ⋁
Evidence: 0.75
¬ Plausible(atenolol, be contraindicated in asthma)

Salient implies Plausible

0.20
Rule weight: 0.28
Evidence weight: 0.70
Similarity weight: 1.00
Evidence: 0.60
Plausible(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.74
¬ Salient(beta blocker, be contraindicated in pulmonary edema)

Similarity expansion

0.66
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.90
Evidence: 0.75
Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.58
¬ Remarkable(beta blocker, be contraindicated in pheochromocytoma)
0.65
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.91
Evidence: 0.58
Typical(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.40
¬ Typical(beta blocker, be contraindicated in myasthenia gravis)
0.63
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.89
Evidence: 0.75
Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.67
¬ Remarkable(beta blocker, be contraindicated in patients with asthma)
0.63
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.91
Evidence: 0.74
Salient(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.72
¬ Salient(beta blocker, be contraindicated in myasthenia gravis)
0.62
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.89
Evidence: 0.75
Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.77
¬ Remarkable(beta blocker, be contraindicated in asthma)
0.62
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.91
Evidence: 0.60
Plausible(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.51
¬ Plausible(beta blocker, be contraindicated in myasthenia gravis)
0.61
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.91
Evidence: 0.75
Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.86
¬ Remarkable(beta blocker, be contraindicated in myasthenia gravis)
0.61
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.90
Evidence: 0.74
Salient(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.78
¬ Salient(beta blocker, be contraindicated in peripheral vascular disease)
0.61
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.90
Evidence: 0.75
Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.83
¬ Remarkable(beta blocker, be contraindicated in peripheral vascular disease)
0.60
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.90
Evidence: 0.74
Salient(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.84
¬ Salient(beta blocker, be contraindicated in pheochromocytoma)
0.60
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.90
Evidence: 0.58
Typical(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.52
¬ Typical(beta blocker, be contraindicated in peripheral vascular disease)
0.60
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.89
Evidence: 0.74
Salient(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.84
¬ Salient(beta blocker, be contraindicated in asthma)
0.59
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.89
Evidence: 0.74
Salient(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in patients with asthma)
0.58
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.90
Evidence: 0.60
Plausible(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.59
¬ Plausible(beta blocker, be contraindicated in peripheral vascular disease)
0.55
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.89
Evidence: 0.60
Plausible(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.69
¬ Plausible(beta blocker, be contraindicated in asthma)
0.55
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.89
Evidence: 0.58
Typical(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.67
¬ Typical(beta blocker, be contraindicated in asthma)
0.53
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.90
Evidence: 0.60
Plausible(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.79
¬ Plausible(beta blocker, be contraindicated in pheochromocytoma)
0.52
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.89
Evidence: 0.60
Plausible(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in patients with asthma)
0.50
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.89
Evidence: 0.58
Typical(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.82
¬ Typical(beta blocker, be contraindicated in patients with asthma)
0.50
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.90
Evidence: 0.58
Typical(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.85
¬ Typical(beta blocker, be contraindicated in pheochromocytoma)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.74
Salient(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.58
¬ Typical(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.60
Plausible(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.58
¬ Typical(beta blocker, be contraindicated in pulmonary edema)

Typicality and Rermarkability incompatibility between a parent and a child

0.33
Rule weight: 0.51
Evidence weight: 0.72
Similarity weight: 0.90
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.37
¬ Typical(vasodilator, be contraindicated in stenosis)
0.27
Rule weight: 0.51
Evidence weight: 0.55
Similarity weight: 0.94
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.59
¬ Typical(agent, cause pulmonary edema)

Typicality and Rermarkability incompatibility between siblings

0.05
Rule weight: 0.14
Evidence weight: 0.41
Similarity weight: 0.89
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.79
¬ Typical(atenolol, be contraindicated in asthma)

Typicality inheritance from parent to child

0.37
Rule weight: 0.48
Evidence weight: 0.84
Similarity weight: 0.90
Evidence: 0.58
Typical(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.37
¬ Typical(vasodilator, be contraindicated in stenosis)
0.34
Rule weight: 0.48
Evidence weight: 0.75
Similarity weight: 0.94
Evidence: 0.58
Typical(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.59
¬ Typical(agent, cause pulmonary edema)